Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein
Rong‐Fu Wang(Houston Methodist), Akio Matsumoto(Kirin (Japan)), Lilia K. Koriazova(Kirin (United States)), Hiroshi Yoshida(Jikei University School of Medicine), L MADURA(Kirin (United States)), Nan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Aixin Song(Kirin (United States)), Lawrence E. Shapiro(Kirin (United States)), David T. Dennis(Kirin (United States)), Jonathan Levin(University of the Witwatersrand)
Cited by 144
Related Papers
Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
|Frontiers in Immunology|2022|880
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
|Journal of Neuroinflammation|2019|746
Evaluation of cell-free DNA approaches for multi-cancer early detection
|Cancer Cell|2022|311
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
|Signal Transduction and Targeted Therapy|2023|289
S-nitrosylation: spectrum and specificity
|Nature Cell Biology|2001|243